Publication | Closed Access

The design and synthesis of novel orally active inhibitors of AP-1 and NF-κB mediated transcriptional activation. SAR of In vitro and In vivo studies

Anti-inflammatoryDrug TargetingVivo StudiesMedicineActive InhibitorsImmunologyPharmacotherapyAnti-cancer AgentPharmacologyTranscriptional ActivationNovel TherapyDrug Discovery